glp 1 agonist and dementia Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease GLP-1 receptor agonists effect on
Description
P., Melguizo, M
2022;146 doi: 10.1016/j.biopha.2021.112563
[DOI] [PubMed] [Google Scholar] 14.After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists
About 70 percent is taken up into the bloodstream in the small intestine and excreted unchanged in urine within 24 hours, while the rest passes through the large intestine and is eliminated within 48 hours
Montero, G
[DOI] [PubMed] [Google Scholar] 20.Salvatore T., Nevola R., Pafundi P.C., Monaco L., Ricozzi C., Imbriani S., Rinaldi L., Sasso F.C
